The ALS Centre Netherlands is based in the University Medical Centre Utrecht (UMC Utrecht) and Amsterdam Medical Centre (AMC).
Our ALS research focuses on environmental and genetic risk factors and the complex interplay between these factors, as well as neuroimaging, transcriptomics and neuroscience using IPSC models. Find information about our research on ALS and other neuromuscular disorders within the UMC Utrecht Brain Center Rudolf Magnus.
- Prof. Leonard van den Berg – Neurologist, Professor of experimental neurology and Coordinator of the ALS Centre Netherlands
- Prof. Jan Veldink – Neurologist and Professor of Human Genetics
- Prof. Jeroen Pasterkamp – Professor of translational neuroscience
- Prof. Anne Visser-Meily – Professor of rehabilitation care
- Martijn van den Heuvel, PhD – Brain researcher
- Carin Schröder, PhD – Psychologist and senior researcher
Read the interview with Prof. Jan Veldink.
We regularly receive requests from patients from abroad to participate in clinical trials at the ALS Centre Netherlands. However, participation of patients from abroad is only possible if the patient speaks Dutch fluently (for reasons of informed consent) and can live in the Netherlands for the duration of the trial. Also, the patient has to fulfill the inclusion criteria of the specific trial. These inclusion criteria differ for each clinical trial, and are decided upon by the pharmaceutical/biotech company, but often involve a maximum time span of two years since symptom onset.